Who
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $25K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 May 2016
- Last trade
- 7 Jul 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jul 2026filed 8 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,000 at $0.00 | filing |
| 7 Jul 2026filed 8 Jul 2026 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,000 at $0.00 | filing |
| 2 Jul 2025filed 3 Jul 2025 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code P | $505,000 at $0.01 | filing |
| 2 Jul 2025filed 3 Jul 2025 | CLRB Cellectar BiosciencesBiotechnology | SEC FORM 4 Bought | $25K5,000 at $4.99 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —290,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —290,000 at $0.00 | filing |
| 8 Dec 2023filed 12 Dec 2023 | CLRB Cellectar BiosciencesBiotechnology | SEC FORM 4 Code A | —42,554 at $0.00 | filing |
| 23 Jun 2023filed 12 Dec 2023 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,000 at $0.00 | filing |
| 17 Jan 2023filed 18 Jan 2023 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,000 at $0.00 | filing |
| 22 Feb 2022filed 24 Feb 2022 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 18 Apr 2017filed 20 Apr 2017 | CLRB Cellectar BiosciencesBiotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 12 May 2016filed 23 May 2016 | CLRB Cellectar Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | $50050,000 at $0.01 | filing |
News
Cellectar Biosciences Eyes 2027 FDA Filing For Iopofosine In Waldenström PatientsCLRB · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Chad J. Kolean; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.